Humacyte Inc Warrant
HUMAW
HUMAW was delisted on the 25th of August, 2026.
13 hedge funds and large institutions have $3.51M invested in Humacyte Inc Warrant in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 6 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
72% more capital invested
Capital invested by funds: $2.04M → $3.51M (+$1.47M)
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
8% more funds holding
Funds holding: 12 → 13 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$351K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$337K |
| 3 |
HF
HRT Financial
New York
|
+$159K |
| 4 |
SCM
Sio Capital Management
New York
|
+$146K |
| 5 |
AGM
Alpine Global Management
New York
|
+$139K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$420K |
| 2 |
ACM
Altium Capital Management
New York
|
-$385K |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$280K |
| 4 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$110K |
| 5 |
CAC
Cowen and Company
New York
|
-$69K |
HUMAW Hedge Fund Activity: Q3 2021 in Review
13 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q3 2021, worth a combined $3.51M — up 72% from $2.04M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new HUMAW positions and 6 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was LMR Partners, adding an estimated $351K. The largest seller was AQR Arbitrage, exiting entirely with an estimated $420K sold.
- 13 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q3 2021, up from 12 in Q2 2021.
- Funds reported $3.51M of Humacyte Inc Warrant stock for Q3 2021, up 72% quarter-over-quarter.
- 7 funds opened new Humacyte Inc Warrant positions in Q3 2021 and 6 closed out, a net change of +1 holder.
- The largest Humacyte Inc Warrant buyer in Q3 2021 was LMR Partners, an estimated $351K added.
- The largest Humacyte Inc Warrant seller in Q3 2021 was AQR Arbitrage, an estimated $420K sold.
Based on aggregated 13F filings for Q3 2021.